Fish oil selectively improves heart function in a mouse model of lipid-induced cardiomyopathy

Journal of Cardiovascular Pharmacology

Volumn 61, Issue 4, 2013, Pages 345-354

  Khan, Raffay S ^a   Chokshi, Aalap ^a   Drosatos, Konstantinos ^a   Jiang, Hongfeng ^a   Yu, Shuiqing ^a   Harris, Collette R ^a   Schulze, P Christian ^a   Homma, Shunichi ^a   Blaner, William S ^a   Shulman, Gerald I ^b   Huang, Li Shin ^a   Goldberg, Ira J ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

diabetes; fibrosis; heart failure; lipotoxicity; omega 3

Indexed keywords

ACYL COENZYME A SYNTHETASE 1; CARRIER PROTEIN; CERAMIDE; CHOLESTEROL; DIACYLGLYCEROL; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; MESSENGER RNA; MYOSIN HEAVY CHAIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CONVALESCENCE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; ENZYME ACTIVATION; FEMALE; GENE OVEREXPRESSION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE FIBROSIS; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SURVIVAL RATE; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ANIMALS; CARDIOMYOPATHIES; COENZYME A LIGASES; FEMALE; FIBROSIS; FISH OILS; HEART FAILURE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOSIN HEAVY CHAINS; PPAR GAMMA; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; SURVIVAL RATE;

EID: 84876394922     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318283d845     Document Type: Article

References (43)

1. Tavazzi L, Maggioni AP, Marchioli R, et al and Gissi-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:1223-1230
2. Kromhout D, Giltay EJ, Jm G, et al; and Alpha Omega Trial Group. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med. 2010;363:2015-2026
3. Marchioli R, Barzi F, Bomba E; and GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105:1897-1903
4. Chen J, Shearer GC, Chen Q, et al. Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts. Circulation. 2011;123:584-593
5. Duda MK, O'Shea KM, Lei B, et al. Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc Res. 2007;76: 303-310
6. Harris WS, Rambjør GS, Windsor SL, et al. n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr. 1997;65: 459-464
7. Leaf A, Xiao YF, Kang JX, et al. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. Pharmacol Ther. 2003;98:355-377
8. Oikawa S, Yokoyama M, Origasa H, et al; and JELIS Investigators Japan. Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis. 2009;206: 535-539
9. Boudina S, Abel ED. Diabetic cardiomyopathy revisted. Circulation. 2007;115:3213-3223
10. Finck BN, Han X, Courtois M, et al. A critical role for PPARalphamediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content. Proc Natl Acad Sci U S A. 2003; 100:1226-1231
11. Chiu HC, Kovacs A, Ford DA, et al. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest. 2001;107:813-822
12. Son NH, Park TS, Yamashita H, et al. Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice. J Clin Invest. 2007; 117:2791-2801
13. Marfella R, Di Filippo C, Portoghese M, et al. Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome. J Lipid Res. 2009;50:2314-2323
14. Balasa A, Sanchez-Valle A, Sadikovic B, et al. Chronic maternal protein deprivation in mice is associated with overexpression of the cohesin-mediator complex in liver of their offspring. J Nutr. 2011; 141:2106-2112
15. Drosatos K, Bharadwaj KG, Lymperopoulos A, et al. Cardiomyocyte lipids impair {beta}-adrenergic receptor function via PKC activation. Am J Physiol Endocrinol Metab. 2011;300:E489-E499
16. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957; 226:497-509
17. Yu C, Chen Y, Cline GW, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 2002;277: 50230-50236
18. Bielawski J, Pierce JS, Snider J, et al. Comprehensive quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods Mol Biol. 2009;579:443-467
19. Son NH, Yu S, Tuinei J, et al. PPARg-induced cardiolipotoxicity in mice is ameliorated by PPARa deficiency despite increases in fatty acid oxidation. J Clin Invest. 2010;120:3443-3454
20. Davidson MM, Nesti C, Palenzuela L, et al. Novel cell lines derived from adult human ventricular cardiomyocytes. J Mol Cell Cardiol 2005;39: 133-47
21. Zhou HY, Chen WD, Zhu DL, et al. The PDE1A-PKCalpha signaling pathway is involved in the upregulation of alpha-smooth muscle actin by TGF-beta1 in adventitial fibroblasts. J Vasc Res. 2010;47:9-15
22. Bosch J, Gerstein HC, Dagenais GR, et al; and ORIGIN Trial Investigators. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med. 2012;367:309-318
23. Rizos EC, Ntzani EE, Bika E, et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. JAMA. 2012;308:1024-1033
24. Takahashi R, Okumura K, Asai T, et al. Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency. Cardiovasc Res. 2005;68:213-223
25. Duda MK, O'Shea KM, Tintinu A, et al. Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res. 2009;81:319-327
26. Fischer R, Dechend R, Qadri F, et al. Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension. Hypertension. 2008;51:540-546
27. Medeiros FJ, Mothe CG, Aguila MB, et al. Long-term intake of edible oils benefits blood pressure and myocardial structure in spontaneously hypertensive rat (SHR) and streptozotocin diabetic SHR. Prostaglandins Other Lipid Mediat. 2005;78:231-248
28. Inoguchi T, Battan R, Handler E, et al. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci U S A. 1992;89:11059-11063
29. Duncan JG, Bharadwaj KG, Fong JL, et al. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators. Circulation. 2010; 121:426-435
30. Lee Y, Naseem RH, Duplomb L, et al. Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice. Proc Natl Acad Sci U S A. 2004;101:13624-13629
31. D'Alessandro ME, Chicco A, Lombardo YB. Dietary fish oil reverses lipotoxicity, altered glucose metabolism, and nPKCepsilon translocation in the heart of dyslipemic insulin-resistant rats. Metabolism. 2008;57: 911-919
32. Eskildsen-Helmond YE, Hahnel D, Reinhardt U, et al. Phospholipid source and molecular species composition of 1,2-diacylglycerol in agonist-stimulated rat cardiomyocytes. Cardiovasc Res. 1998;40:182-190
33. Madani S, Hichami A, Legrand A, et al. Implication of acyl chain of diacylglycerols in activation of different isoforms of protein kinase C. FASEB J. 2001;15:2595-2601
34. Hichami A, Morin C, Rousseau E, et al. Diacylglycerol-containing docosahexaenoic acid in acyl chain modulates airway smooth muscle tone. Am J Respir Cell Mol Biol. 2005;33:378-386
35. Braz JC, Gregory K, Pathak A, et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat Med. 2004;10:248-254
36. Way KJ, Isshiki K, Suzuma K, et al. Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes. Diabetes. 2002;51:2709-2718
37. Connelly KA, Kelly DJ, Zhang Y, et al. Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy. Circ Heart Fail. 2009;2:129-137
38. Seung Kim HF, Weeber EJ, Sweatt JD, et al. Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro. Mol Psychiatry. 2001;6: 246-248
39. Kelly DJ, Chanty A, Gow RM, et al. Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy. J Am Soc Nephrol. 2005;16:1654-1660
40. Sodhi CP, Batlle D, Sahai A. Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: Role of PKC and p38 MAPK. Kidney Int. 2000;58:691-700
41. Subramanian V, Krishnamurthy P, Singh K, et al. Lack of osteopontin improves cardiac function in streptozotocin-induced diabetic mice. Am J Physiol Heart Circ Physiol. 2007;292:673-683
42. Son NH, Park TS, Yamashita H, et al. Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice. J Clin Invest. 2007; 117:2791-2801
43. Li H, Ruan XZ, Powis SH, et al. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: Evidence for a PPAR-gamma-dependent mechanism. Kidney Int. 2005;67:867-874